TCI Wealth Advisors Inc. Sells 202 Shares of Danaher Co. (NYSE:DHR)

TCI Wealth Advisors Inc. cut its position in shares of Danaher Co. (NYSE:DHRFree Report) by 2.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,685 shares of the conglomerate’s stock after selling 202 shares during the period. TCI Wealth Advisors Inc.’s holdings in Danaher were worth $1,764,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. Hamilton Point Investment Advisors LLC boosted its position in Danaher by 0.7% during the 4th quarter. Hamilton Point Investment Advisors LLC now owns 41,799 shares of the conglomerate’s stock valued at $9,606,000 after acquiring an additional 296 shares in the last quarter. Boomfish Wealth Group LLC boosted its position in Danaher by 14.3% during the fourth quarter. Boomfish Wealth Group LLC now owns 3,743 shares of the conglomerate’s stock valued at $859,000 after purchasing an additional 468 shares in the last quarter. Norris Perne & French LLP MI grew its stake in Danaher by 58.8% in the fourth quarter. Norris Perne & French LLP MI now owns 130,356 shares of the conglomerate’s stock valued at $29,923,000 after purchasing an additional 48,261 shares during the last quarter. Strategic Wealth Investment Group LLC raised its holdings in Danaher by 11.5% in the fourth quarter. Strategic Wealth Investment Group LLC now owns 41,176 shares of the conglomerate’s stock worth $9,452,000 after purchasing an additional 4,263 shares in the last quarter. Finally, Gilbert & Cook Inc. boosted its holdings in shares of Danaher by 2.5% in the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after buying an additional 42 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on DHR shares. Robert W. Baird decreased their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday. Raymond James dropped their target price on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st. Jefferies Financial Group decreased their price target on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday. JPMorgan Chase & Co. cut their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Check Out Our Latest Analysis on DHR

Danaher Stock Performance

DHR opened at $223.16 on Friday. The firm has a fifty day moving average price of $235.66 and a 200 day moving average price of $253.24. Danaher Co. has a 1 year low of $221.34 and a 1 year high of $281.70. The stock has a market cap of $161.19 billion, a P/E ratio of 42.27, a P/E/G ratio of 4.22 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same quarter last year, the company posted $2.09 EPS. Equities research analysts anticipate that Danaher Co. will post 8.15 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.